CLINICAL_TRIALS
trial_result
· 2024-02-02
Clinical Trial Update: ILLUMENATE Pivotal Post-Approval Study (PAS) [NA]
Summary
Pivotal post-approval study for ILLUMENATE in peripheral artery disease has completed with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spectranetics Corporation | Conditions: Peripheral Artery Disease | NA | Status: COMPLETED | Results posted: 2024-02-02